The maximum (not average) activity in the region of interest (ROI) should be used, because small ROIs can result in higher average SUVs. In addition, because obese patients generally have higher SUVs in both normal and malignant tissue, lean body mass is preferred in the nominator. Finally, administered activity, the denominator of the equation, is affected by technical factors like extravasation and the amount of FDG remaining in the syringe following injection.
Specific uptake values for FDG in PET must be obtained from the attenuation corrected data. An SUV of 1 g/mL means that the FDG is uniformly distributed throughout the body.
SUV
max of Liver: 2.5 g/mL
SUV
max of Blood: 2.3 g/mL
SUV
max of Spleen: 1.9 g/mL
SUV
max of Bone marrow: 1.0 g/mL
SUV
max of Lung: 0.7 g/mL
Minor changes in scan technique can change SUVs by up to 30%. Delaying image acquisition following injection can also increase SUVs, since FDG continues to accumulate in tumors for up to two hours.
References
Mettler FA and Guiberteau MJ. Chapter 13: PET Imaging. In Essentials of Nuclear Medicine Imaging. Fifth Edition. Saunders, Philadelphia. 2006. pp 375-376.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.